|
|
Volumn 64, Issue 3, 1997, Pages 175-180
|
|
Estrogen replacement therapy for the breast cancer survivor: A reappraisal
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONJUGATED ESTROGEN;
CYTOTOXIC AGENT;
ESTRADIOL;
ESTROGEN;
GESTAGEN;
ORAL CONTRACEPTIVE AGENT;
TAMOXIFEN;
BONE DENSITY;
BONE MINERAL;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER INCIDENCE;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EARLY MENOPAUSE;
EDITORIAL;
ESTROGEN THERAPY;
FEMALE;
HEART PROTECTION;
HIP FRACTURE;
HUMAN;
LIFE EXPECTANCY;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
POSTMENOPAUSE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
BREAST NEOPLASMS;
DISEASE-FREE SURVIVAL;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
RISK FACTORS;
|
|
EID: 0030995571
PISSN: 00224790
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-9098(199703)64:3<175::AID-JSO1>3.0.CO;2-7 Document Type: Editorial |
|
Times cited : (15)
|
|
References (35)
|
